Cargando…
MicroRNA-195-5p Downregulation Inhibits Endothelial Mesenchymal Transition and Myocardial Fibrosis in Diabetic Cardiomyopathy by Targeting Smad7 and Inhibiting Transforming Growth Factor Beta 1-Smads-Snail Pathway
Diabetic cardiomyopathy (DCM) is a complication of diabetes mellitus, which is associated with fibrosis and microRNAs (miRs). This study estimated the mechanism of miR-195-5p in endothelial mesenchymal transition (EndMT) and myocardial fibrosis in DCM. After the establishment of DCM rat models, miR-...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514870/ https://www.ncbi.nlm.nih.gov/pubmed/34658906 http://dx.doi.org/10.3389/fphys.2021.709123 |
_version_ | 1784583490154528768 |
---|---|
author | Ding, Huaisheng Yao, Jianhui Xie, Hongxiang Wang, Chengyu Chen, Jing Wei, Kaiyong Ji, Yangyang Liu, Lihong |
author_facet | Ding, Huaisheng Yao, Jianhui Xie, Hongxiang Wang, Chengyu Chen, Jing Wei, Kaiyong Ji, Yangyang Liu, Lihong |
author_sort | Ding, Huaisheng |
collection | PubMed |
description | Diabetic cardiomyopathy (DCM) is a complication of diabetes mellitus, which is associated with fibrosis and microRNAs (miRs). This study estimated the mechanism of miR-195-5p in endothelial mesenchymal transition (EndMT) and myocardial fibrosis in DCM. After the establishment of DCM rat models, miR-195-5p was silenced by miR-195-5p antagomir. The cardiac function-related indexes diastolic left ventricular anterior wall (LVAW, d), systolic LVAW (d), diastolic left ventricular posterior wall (LVPW, d), systolic LVPW (d), left ventricular ejection fraction (LVEF), and fractional shortening (FS) were measured and miR-195-5p expression in myocardial tissue was detected. Myocardial fibrosis, collagen deposition, and levels of fibrosis markers were detected. Human umbilical vein endothelial cells (HUVECs) were exposed to high glucose (HG) and miR-195-5p was silenced. The levels of fibrosis proteins, endothelial markers, fibrosis markers, EndMT markers, and transforming growth factor beta 1 (TGF-β1)/Smads pathway-related proteins were measured in HUVECs. The interaction between miR-195-5p and Smad7 was verified. In vivo, miR-195-5p was highly expressed in the myocardium of DCM rats. Diastolic and systolic LVAW, diastolic and systolic LVPW were increased and LVEF and FS were decreased. Inhibition of miR-195-5p reduced cardiac dysfunction, myocardial fibrosis, collagen deposition, and EndMT, promoted CD31 and VE-cadehrin expressions, and inhibited α-SMA and vimentin expressions. In vitro, HG-induced high expression of miR-195-5p and the expression changes of endothelial markers CD31, VE-cadehrin and fibrosis markers α-SMA and vimentin were consistent with those in vivo after silencing miR-195-5p. In mechanism, miR-195-5p downregulation blocked EndMT by inhibiting TGF-β1-smads pathway. Smad7 was the direct target of miR-195-5p and silencing miR-195-5p inhibited EndMT by promoting Smad7 expression. Collectively, silencing miR-195-5p inhibits TGF-β1-smads-snail pathway by targeting Smad7, thus inhibiting EndMT and alleviating myocardial fibrosis in DCM. |
format | Online Article Text |
id | pubmed-8514870 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85148702021-10-15 MicroRNA-195-5p Downregulation Inhibits Endothelial Mesenchymal Transition and Myocardial Fibrosis in Diabetic Cardiomyopathy by Targeting Smad7 and Inhibiting Transforming Growth Factor Beta 1-Smads-Snail Pathway Ding, Huaisheng Yao, Jianhui Xie, Hongxiang Wang, Chengyu Chen, Jing Wei, Kaiyong Ji, Yangyang Liu, Lihong Front Physiol Physiology Diabetic cardiomyopathy (DCM) is a complication of diabetes mellitus, which is associated with fibrosis and microRNAs (miRs). This study estimated the mechanism of miR-195-5p in endothelial mesenchymal transition (EndMT) and myocardial fibrosis in DCM. After the establishment of DCM rat models, miR-195-5p was silenced by miR-195-5p antagomir. The cardiac function-related indexes diastolic left ventricular anterior wall (LVAW, d), systolic LVAW (d), diastolic left ventricular posterior wall (LVPW, d), systolic LVPW (d), left ventricular ejection fraction (LVEF), and fractional shortening (FS) were measured and miR-195-5p expression in myocardial tissue was detected. Myocardial fibrosis, collagen deposition, and levels of fibrosis markers were detected. Human umbilical vein endothelial cells (HUVECs) were exposed to high glucose (HG) and miR-195-5p was silenced. The levels of fibrosis proteins, endothelial markers, fibrosis markers, EndMT markers, and transforming growth factor beta 1 (TGF-β1)/Smads pathway-related proteins were measured in HUVECs. The interaction between miR-195-5p and Smad7 was verified. In vivo, miR-195-5p was highly expressed in the myocardium of DCM rats. Diastolic and systolic LVAW, diastolic and systolic LVPW were increased and LVEF and FS were decreased. Inhibition of miR-195-5p reduced cardiac dysfunction, myocardial fibrosis, collagen deposition, and EndMT, promoted CD31 and VE-cadehrin expressions, and inhibited α-SMA and vimentin expressions. In vitro, HG-induced high expression of miR-195-5p and the expression changes of endothelial markers CD31, VE-cadehrin and fibrosis markers α-SMA and vimentin were consistent with those in vivo after silencing miR-195-5p. In mechanism, miR-195-5p downregulation blocked EndMT by inhibiting TGF-β1-smads pathway. Smad7 was the direct target of miR-195-5p and silencing miR-195-5p inhibited EndMT by promoting Smad7 expression. Collectively, silencing miR-195-5p inhibits TGF-β1-smads-snail pathway by targeting Smad7, thus inhibiting EndMT and alleviating myocardial fibrosis in DCM. Frontiers Media S.A. 2021-09-30 /pmc/articles/PMC8514870/ /pubmed/34658906 http://dx.doi.org/10.3389/fphys.2021.709123 Text en Copyright © 2021 Ding, Yao, Xie, Wang, Chen, Wei, Ji and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Physiology Ding, Huaisheng Yao, Jianhui Xie, Hongxiang Wang, Chengyu Chen, Jing Wei, Kaiyong Ji, Yangyang Liu, Lihong MicroRNA-195-5p Downregulation Inhibits Endothelial Mesenchymal Transition and Myocardial Fibrosis in Diabetic Cardiomyopathy by Targeting Smad7 and Inhibiting Transforming Growth Factor Beta 1-Smads-Snail Pathway |
title | MicroRNA-195-5p Downregulation Inhibits Endothelial Mesenchymal Transition and Myocardial Fibrosis in Diabetic Cardiomyopathy by Targeting Smad7 and Inhibiting Transforming Growth Factor Beta 1-Smads-Snail Pathway |
title_full | MicroRNA-195-5p Downregulation Inhibits Endothelial Mesenchymal Transition and Myocardial Fibrosis in Diabetic Cardiomyopathy by Targeting Smad7 and Inhibiting Transforming Growth Factor Beta 1-Smads-Snail Pathway |
title_fullStr | MicroRNA-195-5p Downregulation Inhibits Endothelial Mesenchymal Transition and Myocardial Fibrosis in Diabetic Cardiomyopathy by Targeting Smad7 and Inhibiting Transforming Growth Factor Beta 1-Smads-Snail Pathway |
title_full_unstemmed | MicroRNA-195-5p Downregulation Inhibits Endothelial Mesenchymal Transition and Myocardial Fibrosis in Diabetic Cardiomyopathy by Targeting Smad7 and Inhibiting Transforming Growth Factor Beta 1-Smads-Snail Pathway |
title_short | MicroRNA-195-5p Downregulation Inhibits Endothelial Mesenchymal Transition and Myocardial Fibrosis in Diabetic Cardiomyopathy by Targeting Smad7 and Inhibiting Transforming Growth Factor Beta 1-Smads-Snail Pathway |
title_sort | microrna-195-5p downregulation inhibits endothelial mesenchymal transition and myocardial fibrosis in diabetic cardiomyopathy by targeting smad7 and inhibiting transforming growth factor beta 1-smads-snail pathway |
topic | Physiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514870/ https://www.ncbi.nlm.nih.gov/pubmed/34658906 http://dx.doi.org/10.3389/fphys.2021.709123 |
work_keys_str_mv | AT dinghuaisheng microrna1955pdownregulationinhibitsendothelialmesenchymaltransitionandmyocardialfibrosisindiabeticcardiomyopathybytargetingsmad7andinhibitingtransforminggrowthfactorbeta1smadssnailpathway AT yaojianhui microrna1955pdownregulationinhibitsendothelialmesenchymaltransitionandmyocardialfibrosisindiabeticcardiomyopathybytargetingsmad7andinhibitingtransforminggrowthfactorbeta1smadssnailpathway AT xiehongxiang microrna1955pdownregulationinhibitsendothelialmesenchymaltransitionandmyocardialfibrosisindiabeticcardiomyopathybytargetingsmad7andinhibitingtransforminggrowthfactorbeta1smadssnailpathway AT wangchengyu microrna1955pdownregulationinhibitsendothelialmesenchymaltransitionandmyocardialfibrosisindiabeticcardiomyopathybytargetingsmad7andinhibitingtransforminggrowthfactorbeta1smadssnailpathway AT chenjing microrna1955pdownregulationinhibitsendothelialmesenchymaltransitionandmyocardialfibrosisindiabeticcardiomyopathybytargetingsmad7andinhibitingtransforminggrowthfactorbeta1smadssnailpathway AT weikaiyong microrna1955pdownregulationinhibitsendothelialmesenchymaltransitionandmyocardialfibrosisindiabeticcardiomyopathybytargetingsmad7andinhibitingtransforminggrowthfactorbeta1smadssnailpathway AT jiyangyang microrna1955pdownregulationinhibitsendothelialmesenchymaltransitionandmyocardialfibrosisindiabeticcardiomyopathybytargetingsmad7andinhibitingtransforminggrowthfactorbeta1smadssnailpathway AT liulihong microrna1955pdownregulationinhibitsendothelialmesenchymaltransitionandmyocardialfibrosisindiabeticcardiomyopathybytargetingsmad7andinhibitingtransforminggrowthfactorbeta1smadssnailpathway |